• Unlike regular chemotherapy, rituxan does not cause low blood counts or hair loss.

    和常规化疗不同的是,美罗华不导致血细胞减少或脱发。

    youdao

  • Rituxan is currently approved as a treatment for non-Hodgkin's lymphoma, chronic lymphocytic leukemia and rheumatoid arthritis.

    Rituxan现在已经被批准用于非霍奇金淋巴瘤、慢性淋巴细胞白血病和风湿性关节炎的治疗。

    youdao

  • Patients receiving Rituxan had a higher rate of infections at 37%, compared with 22% in the group of patients who didn't receive Rituxan as maintenance therapy.

    但是服用Rituxan的病人受感染的几率为37%,高于没有服用Rituxan的病人的22%。

    youdao

  • "We like Rituxan, and we think those trials are going to be successful," Flynn said.

    福林说,我们喜欢Rituxan,我们认为试验将会成功。

    youdao

  • Retreatment with Rituxan was not formally evaluated; therefore, the safety and efficacy of retreatment with subsequent courses of Rituxan has not been established.

    使用Rituxan的再治疗还未进行过正式评价,因此Rituxan后续进行再治疗的安全性和有效性还未能证实。

    youdao

  • Objective To investigate the adverse reactions of rituximab (Rituxan and MabThera) in retrospection to provide references for safe and rational drug use clinically.

    目的探讨抗肿瘤靶向药物利妥昔单抗(美罗华)不良反应的特点及规律,为临床安全、合理用药提供参考。

    youdao

  • Objective To investigate the adverse reactions of rituximab (Rituxan and MabThera) in retrospection to provide references for safe and rational drug use clinically.

    目的探讨抗肿瘤靶向药物利妥昔单抗(美罗华)不良反应的特点及规律,为临床安全、合理用药提供参考。

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定